These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4691998)

  • 1. Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide.
    Kerins C; Said SI
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):1014-7. PubMed ID: 4691998
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide.
    Bodanszky M; Klausner YS; Said SI
    Proc Natl Acad Sci U S A; 1973 Feb; 70(2):382-4. PubMed ID: 4510282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate hormones of the gut. V. Vasoactive intestinal peptide (VIP).
    Said SI
    Gastroenterology; 1974 Oct; 67(4):735-7. PubMed ID: 4606296
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.
    Said SI; Mutt V
    Eur J Biochem; 1972 Jul; 28(2):199-204. PubMed ID: 5069712
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasoactive intestinal peptide: secretin-like action on the avian pancreas.
    Dockray GJ
    Experientia; 1973 Dec; 29(12):1510-1. PubMed ID: 4772047
    [No Abstract]   [Full Text] [Related]  

  • 6. Potent peripheral and splanchnic vasodilator peptide from normal gut.
    Said SI; Mutt V
    Nature; 1970 Feb; 225(5235):863-4. PubMed ID: 5415118
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M; Akiyoshi H; Fujii S
    J Biochem; 1977 Oct; 82(4):1073-6. PubMed ID: 924981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo.
    Sánchez V; Goberna R; Calvo JR
    Experientia; 1991 Jun; 47(6):625-6. PubMed ID: 2065763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypeptide with broad biological activity: isolation from small intestine.
    Said SI; Mutt V
    Science; 1970 Sep; 169(3951):1217-8. PubMed ID: 5450698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of VIP on cyclic AMP and glycogen levels in vertebrate retina.
    Schorderet M; Hof P; Magistretti PJ
    Peptides; 1984; 5(2):295-8. PubMed ID: 6089132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperglycemic effect and glycogenolytic action of catecholamines].
    Moratinos J; Ellis S
    Arch Farmacol Toxicol; 1978 Aug; 4(2):189-210. PubMed ID: 31843
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty acid, epinephrine, and glucagon hyperglycemia in normal and depancreatized sheep.
    Phillips RW; House WA; Miller RA; Mott JL; Sooby DL
    Am J Physiol; 1969 Nov; 217(5):1265-8. PubMed ID: 5346289
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of prolonged glucagon administration to turtles (Chrysemys d'Orbignyi).
    Marques M
    Gen Comp Endocrinol; 1967 Aug; 9(1):102-9. PubMed ID: 4862289
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of chlorpropamide on hepatic glycogenolysis and on the glycogenolytic effect of glucagon].
    MAGGI G; RODARI T; GAMBA G
    Rev Iber Endocrinol; 1962; 9():121-3. PubMed ID: 14468273
    [No Abstract]   [Full Text] [Related]  

  • 15. Intestinal and pancreatic glucagon-like peptides. Evidence for identity of higher molecular weight forms.
    Tager HS; Markese J
    J Biol Chem; 1979 Apr; 254(7):2229-33. PubMed ID: 429282
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of glucagon on glycogen in rats and rabbits.
    ROOT MA
    Endocrinology; 1956 Sep; 59(3):340-6. PubMed ID: 13375548
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds.
    Said SI; Mutt V
    Nature; 1977 Jan; 265(5589):84-6. PubMed ID: 834251
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycogenolytic activity of cyclic 3',5'-monophosphates in perfused rat liver.
    Levine RA; Washington A
    Endocrinology; 1970 Aug; 87(2):377-82. PubMed ID: 4316574
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of liver glycogen catabolism during hypercortisolism induced by the administration of dexamethasone in rats.
    Tavoni TM; Obici S; de Castro R Marques A; Minguetti-Câmara VC; Curi R; Bazotte RB
    Pharmacol Rep; 2013; 65(1):144-51. PubMed ID: 23563032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin inhibits insulin secretion and induces hyperglycemia in dogs.
    McDonald TJ; Dupre J; Tatemoto K; Greenberg GR; Radziuk J; Mutt V
    Diabetes; 1985 Feb; 34(2):192-6. PubMed ID: 2578419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.